Tumor Burden In Bangladesh- A Pathology Based Tumor Registry Overview
Mohammad SHAHRIAR, UChicago Research Bangladesh, Bangladesh
KAMAL M. 2
, ISLAM T. 1
, HAQUE S. 1,3
, AHSAN H. 1,3
1 Scientific Program Department,UChicago Research Bangladesh,Uttara,Dhaka,Bangladesh
2 Department of Pathology, Bangabandhu Sheikh Mujib Medical University,Sahhbag,Dhaka,Bangladesh
3 Department of Public Health Science,Biological Science division,University of Chicago,Chicago,IL,USA
Introduction and Purpose: Cancer is a public health concern both in developed and developing countries. Appropriate prevention and surveillance of cancer deserves urgent attention since the disease is expected to be doubled in the next 20 to 25 years in most developing nations. Given the dearth of basic cancer-related data in the country and feasibility considerations, the Department of Pathology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh in collaboration with The University of Chicago, USA has been continuing a pathology-based tumor registry in Bangladesh for the last 4 (from 2012 till date) years at Department of Pathology of BSMMU.
Methods: Basic epidemiological and socioeconomic data have been obtained through a questionnaire from all the patient (total 13040 patient, within 2012-2014) coming to the department lab for diagnostic purpose. Histo and/ or cytopathological data has been obtained from department database.
Result: Middle aged (30-50 years) people are more vulnerable (62%) than other extreme age group developing different tumor including cancer. Female (61.11%) are more prone to develop tumor than male (39.89%). Low socioecomic (86.73%) status and Poor education (< grade 5) level (69.48%) play key role of developing tumor in Bangladesh. In terms of occupation, Housewife (49%) is the most vulnerable group than all others. Skin tumor (55.6%) is the commonest benign tumor among male and Breast tumor (33.28%) in female. In case of malignancy, uterine malignancy (23.38%) atop in female and mouth and oral cavity cancer (11.7%) in male. Uterus (13.18%) is most commonest site of tumor, followed by breast (10.69%) in both sexes.
Conclusion: Although such effort is an underestimate of the true occurrence of the cancers in the population, these data are valuable for formulating any plan or program for epidemiology, prevention and treatment of cancers at the local/ national level.We don't have any dedicated fund.